Fracture Disease (Frakturkrankheit) - Complete Guide
Definition
Fracture disease (German: Frakturkrankheit) is a clinical syndrome of generalized and local complications arising from prolonged immobilization following a fracture. It is NOT the fracture itself, but the cascade of pathological changes that occur in the musculoskeletal and neurovascular systems when a limb or body segment is kept immobile for an extended period. The classic triad is:
Edema + Muscle Atrophy + Dystrophy (algodystrophy/CRPS)
The term was coined in German orthopedic surgery and underscores why early mobilization after fracture fixation is a core principle of modern fracture management.
Illustrative Overview Diagram
1. ETIOLOGY AND CAUSES
The root cause is mechanical unloading of bone and soft tissues due to immobilization. Several contexts lead to this:
Primary Causes
| Cause | Mechanism |
|---|
| Fracture treated with cast/plaster | Rigid immobilization prevents all movement |
| Fracture treated conservatively | Prolonged bed rest or splinting |
| Post-surgical immobilization | Rest after internal fixation before mobilization begins |
| Soft-tissue injury with immobilization | Sprains, dislocations kept immobile |
| Neurological injury co-existing with fracture | Paralysis compounds disuse |
Predisposing / Risk Factors
- Age - elderly patients have less physiological reserve
- Pre-existing osteoporosis - already reduced bone density
- Diabetes mellitus - impairs autonomic regulation and healing
- Peripheral vascular disease - reduces trophic supply
- Psychological factors - pain catastrophizing, kinesiophobia (fear of movement)
- Neurological deficit - spinal cord injury, stroke
- Duration of immobilization - longer = worse
From General Anatomy and Musculoskeletal System (THIEME Atlas): "Immediate mobilization prevents thrombosis, emboli, decubitus, and fracture disease, e.g., edema and dystrophy."
2. PATHOLOGY AND PATHOPHYSIOLOGY
A. Disuse Osteoporosis (Bone Pathology)
Mechanism:
- Normal bone remodeling depends on Wolff's Law - bone remodels along lines of mechanical stress
- Immobilization removes mechanical loading - osteoclast activity exceeds osteoblast activity
- Rapid bone mineral loss: up to 1-3% per week in immobilized limbs
- Sclerostin (an osteoblast inhibitor) rises, further suppressing bone formation
Histopathology:
- Thinned cortex with endosteal scalloping
- Reduced trabecular density and spacing
- Periarticular (juxta-articular) demineralization is the hallmark
- Pattern is "spotty/patchy" - distinguishes it from systemic osteoporosis
B. Muscle Atrophy
Mechanism:
- Loss of nerve stimulation and mechanical loading leads to protein catabolism
- Type II (fast-twitch) muscle fibers atrophy fastest
- Histology: reduced fiber diameter, increased connective tissue infiltration
- Rate: ~3% muscle mass lost per day in complete immobilization
C. Joint Contracture / Stiffness
Mechanism:
- Reduced synovial fluid circulation leads to synovial fibrosis
- Joint capsule and periarticular structures undergo fibrous contracture
- Intra-articular adhesions form
- Cartilage softening (chondromalacia) from reduced compression loading
D. Edema
Mechanism:
- Reduced muscle pump action impairs venous and lymphatic return
- Capillary stasis and increased hydrostatic pressure in the limb
- Protein-rich interstitial edema accumulates in soft tissues
E. Deep Vein Thrombosis (DVT)
Mechanism:
- Virchow's Triad in fracture disease:
- Stasis - immobilization reduces venous flow
- Hypercoagulability - injury-related coagulation activation
- Endothelial injury - direct trauma to vessel walls
- Proximal DVT (femoral, popliteal) can lead to pulmonary embolism
F. Complex Regional Pain Syndrome (CRPS) / Algodystrophy / Sudeck's Atrophy
This is the most serious component of fracture disease. Previously called:
- Reflex Sympathetic Dystrophy (RSD)
- Sudeck's Atrophy
- Algodystrophy / Algoneurodystrophy
- Post-traumatic painful osteoporosis
- Shoulder-hand syndrome (when upper limb affected)
Pathophysiology:
- Poorly understood - involves dysregulation of the autonomic nervous system
- Central and peripheral sensitization of pain pathways
- Sympathetic nervous system activation causes vasomotor instability
- Neurogenic inflammation (substance P, bradykinin, neuropeptides)
- Disuse and kinesiophobia (fear of movement) perpetuate and worsen the syndrome
- Inflammatory mediators cause trophic skin and bone changes
From Rockwood and Green's Fractures in Adults (10th ed., 2025): "CRPS refers to an unexplained pain syndrome...characterized by disproportionate pain and accompanying autonomic and motor disturbances...Nowadays it is considered a rare, devastating complication of minor injury caused by disuse and seen in any patient at every age."
3. SIGNS AND SYMPTOMS
Local Signs and Symptoms
| Category | Symptoms (Reported) | Signs (Observed on Exam) |
|---|
| Pain | Burning, disproportionate pain; allodynia; hyperesthesia | Hyperalgesia to pinprick; allodynia to light touch |
| Vasomotor | Skin color changes; temperature difference between limbs | Temperature asymmetry >1°C; skin color/asymmetry |
| Edema/Sudomotor | Swelling; increased/decreased sweating | Pitting or non-pitting edema; sweating asymmetry |
| Motor/Trophic | Weakness; reduced range of motion; tremor | Muscle wasting; joint stiffness; dystonia; trophic changes (nails, hair, skin) |
Stages of CRPS/Algodystrophy (Classic Three-Stage Model)
Stage 1 (Acute, 0-3 months)
- Burning pain, hyperalgesia
- Warm, red, edematous limb
- Increased sweating
- Rapid hair and nail growth (paradoxically)
- X-ray: patchy periarticular osteoporosis beginning
Stage 2 (Dystrophic, 3-6 months)
- Persistent pain, allodynia
- Skin becomes cool, pale/cyanotic, shiny
- Edema becomes hard/brawny
- Joint stiffness increases
- X-ray: diffuse osteoporosis more evident
Stage 3 (Atrophic, >6 months)
- Pain may diminish but disability is severe
- Skin atrophic, glossy, cold
- Irreversible muscle atrophy and joint contracture
- Subcutaneous tissue atrophied
- X-ray: severe diffuse osteoporosis
General Signs of Fracture Disease
- Muscle wasting visible and measurable (limb circumference)
- Pressure sores (decubitus ulcers) in bed-bound patients
- Deep vein thrombosis signs (leg swelling, Homan's sign - not specific)
- Pulmonary embolism (dyspnea, pleuritic chest pain, hemoptysis)
4. INVESTIGATIONS
Radiological Investigations
Plain X-ray (First-line)
- Periarticular osteoporosis - "spotty" or "moth-eaten" pattern
- Thinning of cortex
- Reduced trabecular density
- Soft tissue swelling
- Late: severe diffuse osteoporosis
Bone Scintigraphy (Technetium-99m)
- Stage 1: Increased uptake (hot scan) - hypervascular, increased bone turnover
- Stage 3: Decreased uptake (cold scan) - atrophic, reduced perfusion
- Helpful for staging and distinguishing from other conditions
MRI
- Early bone marrow edema
- Periarticular changes
- Rules out other pathology (osteomyelitis, tumor)
- Soft tissue evaluation
CT Scan
- Better assessment of bone mineral density changes
- Identifies subtle cortical thinning
- Useful for planning surgical intervention
Dual-energy X-ray Absorptiometry (DEXA)
- Quantifies bone mineral density loss
- Monitors response to treatment
Laboratory Investigations
| Test | Relevance |
|---|
| Full blood count (FBC) | Baseline; infection screen |
| ESR/CRP | Elevated in inflammatory phase of CRPS |
| Serum calcium, phosphate, ALP | Bone metabolism markers |
| Serum D-dimer | Screening for DVT/PE |
| Urine calcium | Increased in disuse osteoporosis (hypercalciuria) |
| Urinalysis | Kidney stones (from hypercalciuria) |
Specialized Tests
For DVT:
- Doppler ultrasound of lower limb veins (gold standard for DVT)
- CT pulmonary angiography (if PE suspected)
- V/Q scan
For CRPS:
- Thermography (temperature asymmetry >1°C is significant)
- Quantitative sudomotor axon reflex testing (QSART) - sweat abnormalities
- Three-phase bone scan
- Budapest Criteria assessment (clinical diagnosis - see below)
Budapest Diagnostic Criteria for CRPS (Budapest, 2003)
To diagnose CRPS, the patient must:
- Have continuing pain disproportionate to the inciting event
- Report at least 1 symptom in 3 of 4 categories:
- Sensory (hyperesthesia/allodynia)
- Vasomotor (temperature/color asymmetry)
- Sudomotor/Edema (sweating changes, edema)
- Motor/Trophic (decreased ROM, weakness, trophic changes)
- Show at least 1 sign at examination in 2 or more categories (same categories)
- No other diagnosis better explains the signs and symptoms
5. TREATMENT
Treatment of fracture disease is prevention-first, with rehabilitation as the cornerstone.
A. PREVENTION (Most Important)
The best treatment is prevention through early mobilization after fracture stabilization.
Surgical Principles (Osteosynthesis):
- Rigid internal fixation (plates, screws, intramedullary nails, tension-band wiring) allows immediate mobilization
- Advantages over cast: exact repositioning, early movement, prevents muscle atrophy, disuse osteoporosis, DVT, and dystrophy
- External fixation for complex/open fractures - still allows partial loading
Physical Measures:
- Early weight-bearing as soon as fracture stability allows
- Active movement therapy - mobilization of joints proximal and distal to fracture
- Elevation of the limb to reduce edema
- Compression stockings/bandaging to prevent edema and DVT
B. TREATMENT OF SPECIFIC COMPONENTS
1. Disuse Osteoporosis
- Weight-bearing exercise / physical therapy
- Calcium supplementation (1000-1500 mg/day) + Vitamin D (800-1000 IU/day)
- Bisphosphonates (alendronate, zoledronic acid) if severe
- Avoid tobacco, alcohol
- Monitor with DEXA scans
2. Muscle Atrophy
- Progressive resistance exercises
- Physiotherapy - electrical muscle stimulation (EMS) for paralyzed limbs
- Protein-rich diet (1.2-1.5 g/kg/day)
- Occupational therapy for functional retraining
3. Joint Contracture
- Passive and active range-of-motion exercises
- Serial splinting / dynamic splinting
- Manipulation under anesthesia (MUA) for established contractures
- Surgical release (arthrolysis, capsulotomy) in severe cases
4. Edema Management
- Elevation of the affected limb
- Compression bandaging / stockings
- Lymphedema massage (manual lymphatic drainage)
- Diuretics - short-term use if severe
5. DVT Prevention and Treatment
- Low molecular weight heparin (LMWH) - e.g., enoxaparin - for prophylaxis
- Mechanical prophylaxis - intermittent pneumatic compression, anti-embolism stockings
- Early mobilization
- Established DVT: therapeutic anticoagulation (LMWH/DOAC for 3-6 months)
- Established PE: anticoagulation ± thrombolysis in severe cases
6. CRPS / Algodystrophy Treatment
Multidisciplinary approach is essential.
| Modality | Details |
|---|
| Physical Therapy | Graded exposure, pain exposure physical therapy (PEPT), desensitization; KEY treatment |
| Analgesics | NSAIDs, paracetamol for mild; tramadol/opioids for severe |
| Neuropathic agents | Gabapentin, pregabalin for neuropathic pain |
| Corticosteroids | Short course in acute phase (prednisolone) |
| Bisphosphonates | Pamidronate, alendronate - reduce bone pain and osteoporosis |
| Calcitonin | Analgesic + antiresorptive effect (intranasal or injection) |
| Sympathetic nerve block | Stellate ganglion / lumbar sympathetic block - provides temporary relief |
| Spinal cord stimulation | For chronic refractory CRPS - reduces pain via dorsal column modulation |
| Psychological therapy | CBT, exposure in vivo, graded motor imagery - addresses kinesiophobia |
| TENS | Transcutaneous electrical nerve stimulation for pain relief |
| Mannitol IV | Free radical scavenger - used in acute severe CRPS |
| Vitamin C | 500 mg/day post-fracture shown to reduce CRPS incidence (particularly wrist fractures) |
| Amputation | Last resort in severe intractable cases with severe tissue destruction |
From Rockwood and Green's Fractures in Adults: "After the introduction of several more cognitive and behavioral treatment methods, such as pain exposure physical therapy (PEPT) and exposure in vivo, it appeared that disuse and kinesiophobia played an important role in the development and maintenance of CRPS."
6. PROGNOSIS
| Outcome Factor | Better Prognosis | Worse Prognosis |
|---|
| Duration of immobilization | Short | Long (>6 weeks) |
| Age | Young | Elderly |
| Stage of CRPS at diagnosis | Stage 1 (acute) | Stage 3 (atrophic) |
| Treatment approach | Early, multidisciplinary | Delayed, unimodal |
| Patient compliance | Good | Poor (kinesiophobia) |
| Co-morbidities | None | Diabetes, vascular disease |
- Most patients with early-stage fracture disease recover fully with appropriate physiotherapy and mobilization.
- Established CRPS (Stage 3) has a poor prognosis and can result in permanent disability.
- Suicide attempts and severe depression have been documented in long-standing CRPS cases.
Summary Concept Map
FRACTURE + PROLONGED IMMOBILIZATION
|
┌──────┴──────────────────────────────┐
| |
LOCAL EFFECTS SYSTEMIC EFFECTS
| |
┌──┴────────────────────┐ DVT / PE
| | |
Disuse Muscle Joint
Osteo- Atrophy Stiffness
porosis /Contracture
|
Sudeck's Atrophy
(CRPS - Algodystrophy)
|
├─ Pain (burning, disproportionate)
├─ Vasomotor changes (color, temperature)
├─ Edema + Sweating abnormalities
└─ Motor/Trophic changes
TREATMENT:
Prevention > Early mobilization after osteosynthesis
Rehabilitation > Physiotherapy, PEPT, graded exposure
Pharmacology > Bisphosphonates, Ca/Vit D, neuropathics
Intervention > Sympathetic blocks, SCS, surgery
Sources:
- General Anatomy and Musculoskeletal System - THIEME Atlas of Anatomy, Schuenke et al.
- Rockwood and Green's Fractures in Adults, 10th Edition (2025), Chapter 27: CRPS
- Pathologic Fractures - StatPearls, Rizzo & Kenan (2023), NCBI Bookshelf NBK559077